Table 1.
Patients’ characteristics.
| N | % | |
|---|---|---|
| Age (N = 396) | ||
| ≥45 and ≤65 | 186 | (47.0) |
| <45 | 42 | (10.6) |
| >65 | 168 | (42.4) |
| Grading (N = 324) | ||
| 1 | 11 | 3.4 |
| 2 | 162 | 0.50 |
| 3 | 151 | 46.6 |
| Histotype (N = 390) | ||
| Ductal | 318 | (81.6) |
| Lobular | 59 | (15.1) |
| Others | 13 | (3.3) |
| ER status (N = 334) | ||
| Negative | 80 | (24.0) |
| Positve | 254 | (76.0) |
| PR status (N = 328) | ||
| Negative | 126 | (38.4) |
| Positve | 202 | (61.6) |
| Ki67 (N = 334) | ||
| <14% | 70 | (21.8) |
| ≥14% | 251 | (78.2) |
| HER2 (N = 334) | ||
| Uncertain | 2 | (0.6) |
| Negative | 245 | (73.4) |
| Positive | 87 | (26.0) |
| Profiles (N = 310) | ||
| Luminal A | 44 | (14.2) |
| Luminal B | 151 | (48.7) |
| Luminal HER2 | 43 | (13.9) |
| HER2 Positive | 35 | (11.3) |
| Triple Negative | 37 | (11.9) |
| ECOG Performance Status (N = 389) | ||
| 0 | 204 | (52.4) |
| 1 | 150 | (38.6) |
| 2 | 35 | (9.0) |
| Number of Sites (N = 396) | ||
| 1 | 213 | (53.8) |
| 2 | 105 | (26.5) |
| 3 | 53 | (13.4) |
| 4 | 19 | (4.8) |
| 5 | 5 | (1.3) |
| 6 | 1 | (0.2) |